Syenex, Inc.

Evanston, IL · Founded 2022 · CIK 0001935303 · Biotech · Private

Cloud platform for genomics medicine development and deployment

syenex.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$8.9M
2 Form D · Jan 2025
20 months since last filing
Contracts
—
No federal contracts on record
Patents
4
0 granted · 4 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$225,000
Private capital raisedForm D · SEC$8,662,428
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1857Ibex Investment Holdings II LLC—$1.0M
1858Purinomia Biotech, Inc.—$10M
1859Apollomics Inc.—$10M
1860Syenex, Inc.—$8.9M
1861SMSbiotech, Inc.—$16M
1862Avotres Inc.—$8.0M
1863Bit Global Digital Asset Management Co., Ltd.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 1 related persons
  • John RosanelliDirector · Executive Officer

Patents

USPTO · 0 granted of 4
  • Receptor Engagement-mediated Enhancement Of Biologics Deliveryapplication
  • Engineered Cell-derived Lipid Bilayer Particles And Uses Thereofapplication
  • Engineered Lipid Bilayer Particles Displaying Sirpaapplication
  • Engineered Cell-derived Lipid Bilayer Particles And Uses Thereofapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.